Chris Pasquale
Stock Analyst at Guggenheim
(n/a)
# 4,712
Out of 4,876 analysts
6
Total ratings
n/a
Success rate
-28.27%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Chris Pasquale
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ZIMV ZimVie | Initiates: Neutral | n/a | $9.26 | - | 1 | Mar 18, 2022 | |
| ICAD iCAD, Inc. | Downgrades: Neutral | n/a | $3.80 | - | 2 | Jan 18, 2022 | |
| DXCM DexCom | Upgrades: Buy | $145 | $86.33 | +67.96% | 1 | Jan 7, 2022 | |
| COO The Cooper Companies | Upgrades: Buy | $124 | $71.14 | +73.95% | 1 | Jan 3, 2022 | |
| PRCT PROCEPT BioRobotics | Initiates: Buy | $45 | $56.91 | -20.93% | 1 | Oct 11, 2021 |
ZimVie
Mar 18, 2022
Initiates: Neutral
Price Target: n/a
Current: $9.26
Upside: -
iCAD, Inc.
Jan 18, 2022
Downgrades: Neutral
Price Target: n/a
Current: $3.80
Upside: -
DexCom
Jan 7, 2022
Upgrades: Buy
Price Target: $145
Current: $86.33
Upside: +67.96%
The Cooper Companies
Jan 3, 2022
Upgrades: Buy
Price Target: $124
Current: $71.14
Upside: +73.95%
PROCEPT BioRobotics
Oct 11, 2021
Initiates: Buy
Price Target: $45
Current: $56.91
Upside: -20.93%